An official State of Kansas government website.

Government Website icon

The .gov means it's official.
A .gov website belongs to an official government organization in the United States.

Padlock icon

The site is secure.
The https:// or lock icon ensures you're safely connected to the website and any information you provide is encrypted.

Publications iconKansas Register

Print icon

Volume 42 - Issue 41 - October 12, 2023

State of Kansas

Board of Pharmacy

Permanent Administrative Regulations

Article 2.—DRUGSTORES

68-2-24. Pharmacy owner responsibilities. (a) Each pharmacy owner shall ensure that the pharmacy is operated in compliance with the Kansas pharmacy act, the state and federal uniform controlled substances act, the state and federal food, drug, and cosmetic act, the state prescription monitoring program act, and all applicable regulations.

(b) Each pharmacy owner shall ensure that all policies and procedures of the pharmacy are in compliance with the Kansas pharmacy act, the state and federal uniform controlled substances act, the state and federal food, drug, and cosmetic act, the state prescription monitoring program act, and all applicable regulations.

(c) Each pharmacy owner shall not prohibit or prevent a pharmacist, pharmacist intern, or pharmacy technician from complying with the Kansas pharmacy act, the state and federal uniform controlled substances act, the state and federal food, drug, and cosmetic act, the state prescription monitoring program act, and all applicable regulations.

(d) Each pharmacy owner shall not penalize, prohibit, or prevent a pharmacist from conducting an in-person inspection of a prescription, drug or device, or product verification.

(e) Each pharmacy owner shall not permit an individual to be in the pharmacy that has had a license or registration denied, revoked, or suspended by the board, unless the licensee or registrant has subsequently been issued an active license or registration by the board. (Authorized by K.S.A. 65-1630 and K.S.A. 2022 Supp. 65-1643; implementing K.S.A. 2022 Supp. 65-1626, K.S.A. 2022 Supp. 65-1627, K.S.A. 65-1642, K.S.A. 2022 Supp. 65-1643, K.S.A. 65-1648, K.S.A. 65-1663, and K.S.A. 65-1676; effective Oct. 27, 2023.)

Article 20.—CONTROLLED SUBSTANCES

68-20-23. (Authorized by and implementing K.S.A. 65-4102; effective, T-68-11-6-08, Nov. 6, 2008; effective March 6, 2009; revoked Oct. 27, 2023.)

68-20-31. (Authorized by and implementing K.S.A. 2014 Supp. 65-4102; effective, T-68-1-23-15, Jan. 23, 2015; effective June 5, 2015; revoked Oct. 27, 2023.)

68-20-32. 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine included in schedule I. (a) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (other name: flubromazolam), including its salts, isomers, and salts of isomers, shall be classified as a schedule I controlled substance.

(b) This regulation shall expire on July 1, 2024. (Authorized by and implementing K.S.A. 65-4102; effective, T-68-7-17-23, July 17, 2023; effective Oct. 27, 2023.)

Alexandra Blasi
Executive Administrator
Board of Pharmacy

Doc. No. 051559

Secretary of State Seal